Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190


Cutaneous tests and interest of iobitridol in non-immediate hypersensitivity to contrast media: a case series of 43 patients.

Gaudin O, Deschamps O, Duong TA, Gener G, Paul M, Luciani A, Chosidow O, Wolkenstein P, Ingen-Housz-Oro S, Assier H.

J Eur Acad Dermatol Venereol. 2019 Dec 9. doi: 10.1111/jdv.16139. [Epub ahead of print] No abstract available.


Cross-reactivity in beta-lactams after a non-immediate cutaneous adverse reaction: experience of a reference centre for toxic bullous diseases and severe cutaneous adverse reactions.

Bérot V, Gener G, Ingen-Housz-Oro S, Gaudin O, Paul M, Chosidow O, Wolkenstein P, Assier H.

J Eur Acad Dermatol Venereol. 2019 Sep 30. doi: 10.1111/jdv.15986. [Epub ahead of print]


Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect.

Chen DM, Odueyungbo A, Csinady E, Gearhart L, Lehane P, Cheu M, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, Caillot F, Golinski ML, Labeille B, Picard-Dahan C, Paul C, Richard MA, Bouaziz JD, Duvert-Lehembre S, Bernard P, Caux F, Alexandre M, Ingen-Housz-Oro S, Vabres P, Delaporte E, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bedane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Benichou J, Musette P, Joly P; French Study Group on Autoimmune Bullous Diseases.

Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18482. [Epub ahead of print]


Incidence of and mortality from epidermal necrolysis (Stevens-Johnson syndrome/toxic epidermal necrolysis) in France during 2003-16: a four-source capture-recapture estimate.

Chaby G, Maldini C, Haddad C, Lebrun-Vignes B, Hemery F, Ingen-Housz-Oro S, Gonzalez-Chiappe S, Wolkenstein P, Chosidow O, Mahr A, Fardet L.

Br J Dermatol. 2019 Aug 9. doi: 10.1111/bjd.18424. [Epub ahead of print]


Health-related quality of life and long-term sequelae in survivors of epidermal necrolysis: an observational study of 57 patients.

Ingen-Housz-Oro S, Alves A, Colin A, Ouedraogo R, Layese R, Canoui-Poitrine F, Chosidow O, Mekontso-Dessap A, Wolkenstein P, de Prost N.

Br J Dermatol. 2019 Aug 5. doi: 10.1111/bjd.18387. [Epub ahead of print]


Trends in mortality rates for Stevens-Johnson syndrome and toxic epidermal necrolysis: experience of a single centre in France between 1997 and 2017.

Bettuzzi T, Penso L, de Prost N, Hemery F, Hua C, Colin A, Mekontso-Dessap A, Fardet L, Chosidow O, Wolkenstein P, Sbidian E, Ingen-Housz-Oro S.

Br J Dermatol. 2020 Jan;182(1):247-248. doi: 10.1111/bjd.18360. Epub 2019 Sep 11. No abstract available.


Thalidomide in Severe Hidradenitis Suppurativa: A Therapeutic Option.

Hotz C, Sbidian E, Ingen-Housz-Oro S, Chosidow O, Wolkenstein P.

Acta Derm Venereol. 2019 Nov 1;99(12):1170-1171. doi: 10.2340/00015555-3268. No abstract available.


Individual- and hospital-level factors associated with epidermal necrolysis mortality: a nationwide multilevel study, France, 2012-2016.

Traikia C, Hua C, Le Cleach L, de Prost N, Hemery F, Bettuzzi T, Chosidow O, Wolkenstein P, Ingen-Housz-Oro S, Sbidian E.

Br J Dermatol. 2019 Jul 1. doi: 10.1111/bjd.18294. [Epub ahead of print]


Acute generalized exanthematous pustulosis and epidermal necrolysis differ in innate cytokine patterns.

Lalevée S, Audureau E, Riou A, Colin A, Anquetin M, Barau C, Valeyrie-Allanore L, Delfau-Larue MH, Chosidow O, Wolkenstein P, Ingen-Housz-Oro S, Hüe S.

Clin Exp Allergy. 2019 Sep;49(9):1258-1261. doi: 10.1111/cea.13449. Epub 2019 Jul 7. No abstract available.


Acute exanthemas: a prospective study of 98 adult patients with an emphasis on cytokinic and metagenomic investigation.

Deschamps O, Ortonne N, Hüe S, Rodriguez C, Deschodt C, Hirsch G, Colin A, Grégoire L, Delfau-Larue MH, Chosidow O, Wolkenstein P, Ingen-Housz-Oro S.

Br J Dermatol. 2019 May 25. doi: 10.1111/bjd.18166. [Epub ahead of print]


[Hemophagocytic lymphohistiocytosis with granulomatosis and diffuse T-cell infiltration associated with disseminated Nocardiosis and pulmonary infection due to Streptomyces spp].

Canouï E, Ingen-Housz-Oro S, Ortonne N, Lebeaux D, Rodriguez-Nava V, Godeau B, Mahévas M.

Rev Med Interne. 2019 Jul;40(7):457-461. doi: 10.1016/j.revmed.2019.04.013. Epub 2019 May 15. French.


Disabling ocular sequelae of epidermal necrolysis: risk factors during the acute phase and associated sequelae.

Hajj C, Ezzedine K, Thorel D, Delcampe A, Royer G, Hua C, Colin A, de Prost N, Muraine M, Chosidow O, Wolkenstein P, Gueudry J, Ingen-Housz-Oro S.

Br J Dermatol. 2019 Aug;181(2):421-422. doi: 10.1111/bjd.18023. Epub 2019 Jun 6. No abstract available.


[Update of the French recommendations for the management of pemphigus].

Jelti L, Prost-Squarcioni C, Ingen-Housz-Oro S, Caux F, Bernard P, Bedane C, Alexandre M, Dereure O, Quereux G, Le Bidre E, Plée J, Picard-Dahan C, Le Roux-Villet C, Duvert-Lehembre S, Richard MA, Delaporte E, Debarbieux S, Jullien D, D'Incan M, Konstantinou MP, Bouaziz JD, Tancrède-Bohin E, Doutre MS, Bourgault Villada I, Cordel N, Sassolas B, Viguier MA, Mellottée B, Jouen F, Hebert V, Joly P; Centre de référence des maladies bulleuses auto-immunes (MALIBUL); Groupe Bulles de la SFD et la Filière des maladies rares dermatologiques (FIMARAD).

Ann Dermatol Venereol. 2019 Apr;146(4):279-286. doi: 10.1016/j.annder.2019.01.018. Epub 2019 Mar 29. French. No abstract available.


[Delayed hypersensitivity to anti-tuberculosis drugs. Proposed practical management plan for exanthema: when to stop, which allergological investigations to perform, and how to restart treatment].

Ingen-Housz-Oro S, Assier H, Gener G, Milpied B, Soria A, Bernier C, Descamps V, Tetart F, Staumont-Sallé D, Valeyrie-Allanore L, Valois A, Sassolas B, Bensaid B, Lebrun-Vignes B, Barbaud A; Groupe FISARD de la SFD.

Ann Dermatol Venereol. 2019 Apr;146(4):313-318. doi: 10.1016/j.annder.2019.01.010. Epub 2019 Mar 21. French. No abstract available.


Incidence of bloodstream infections and predictive value of qualitative and quantitative skin cultures of patients with overlap syndrome or toxic epidermal necrolysis: A retrospective observational cohort study of 98 cases.

Lecadet A, Woerther PL, Hua C, Colin A, Gomart C, Decousser JW, Mekontso Dessap A, Wolkenstein P, Chosidow O, de Prost N, Ingen-Housz-Oro S.

J Am Acad Dermatol. 2019 Aug;81(2):342-347. doi: 10.1016/j.jaad.2019.03.030. Epub 2019 Mar 16.


Cutaneous lymphomas appearing during treatment with biologics: 44 cases from the French Study Group on Cutaneous Lymphomas and French Pharmacovigilance Database.

Dequidt L, Franck N, Sanchez-Pena P, Dalle S, Adamski H, Boulinguez S, Ingen-Housz-Oro S, Ram-Wolff C, Boccara O, Bonnet N, Cortes B, Gouraud A, Grange F, Le Corre Y, Quereux G, De Masson A, Schmutz JL, Skowron F, Verneuil L, Beylot-Barry M.

Br J Dermatol. 2019 Sep;181(3):616-618. doi: 10.1111/bjd.17834. Epub 2019 May 29. No abstract available.


Lookalike and soundalike drugs: a potential cause of cutaneous adverse reactions to drugs.

Cassius C, Davis CJ, Bravard P, Carre-Gislard D, Modiano P, Lebrun-Vignes B, Ingen-Housz-Oro S, Chosidow O.

Br J Dermatol. 2019 Sep;181(3):626-627. doi: 10.1111/bjd.17842. Epub 2019 Jun 18. No abstract available.


Response to 'Cutaneous eruptions associated with haematological malignancies: the need for a unifying nomenclature'.

Visseaux L, Durlach A, Barete S, Ingen-Housz-Oro S, Ortonne N, Grange F.

J Eur Acad Dermatol Venereol. 2019 May;33(5):e193. doi: 10.1111/jdv.15451. Epub 2019 Mar 4. No abstract available.


Interventions for erythema multiforme: a systematic review.

de Risi-Pugliese T, Sbidian E, Ingen-Housz-Oro S, Le Cleach L.

J Eur Acad Dermatol Venereol. 2019 May;33(5):842-849. doi: 10.1111/jdv.15447. Epub 2019 Feb 28.


Dark skin phototype is associated with more severe ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.

Thorel D, Delcampe A, Ingen-Housz-Oro S, Hajj C, Gabison E, Chosidow O, Wolkenstein P, Royer G, Ezzedine K, Muraine M, Gueudry J.

Br J Dermatol. 2019 Jul;181(1):212-213. doi: 10.1111/bjd.17627. Epub 2019 Apr 29. No abstract available.


Higher Frequency of Dipeptidyl Peptidase-4 Inhibitor Intake in Bullous Pemphigoid Patients than in the French General Population.

Plaquevent M, Tétart F, Fardet L, Ingen-Housz-Oro S, Valeyrie-Allanore L, Bernard P, Hebert V, Roussel A, Avenel-Audran M, Chaby G, D'Incan M, Ferrier-Le-Bouedec MC, Duvert-Lehembre S, Picard-Dahan C, Jeudy G, Collet E, Labeille B, Morice C, Richard MA, Bourgault-Villada I, Litrowski N, Bara C, Mahe E, Prost-Squarcioni C, Alexandre M, Quereux G, Bernier C, Soria A, Thomas-Beaulieu D, Pauwels C, Dereure O, Benichou J, Joly P; French Investigators for Skin Adverse Reaction to Drugs; French Study Group on Autoimmune Bullous Skin Diseases.

J Invest Dermatol. 2019 Apr;139(4):835-841. doi: 10.1016/j.jid.2018.10.045. Epub 2018 Dec 10.


Drug-induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases.

Garel B, Ingen-Housz-Oro S, Afriat D, Prost-Squarcioni C, Tétart F, Bensaid B, Bara Passot C, Beylot-Barry M, Descamps V, Duvert-Lehembre S, Grootenboer-Mignot S, Jeudy G, Soria A, Valnet-Rabier MB, Barbaud A, Caux F, Lebrun-Vignes B.

Br J Clin Pharmacol. 2019 Mar;85(3):570-579. doi: 10.1111/bcp.13827. Epub 2019 Jan 4.


Gastrointestinal involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective case series.

Gendreau S, Amiot A, Le Baleur Y, Charpy C, Wolkenstein P, Chosidow O, Mekontso Dessap A, Ingen-Housz-Oro S, de Prost N.

Br J Dermatol. 2019 May;180(5):1234-1235. doi: 10.1111/bjd.17428. Epub 2019 Feb 13. No abstract available.


[The role of genetics, pathology and immunology laboratories in the management of rare dermatological diseases].

Vidaud D, Silve C, Leclerc-Mercier S, Hüe S, Ingen-Housz-Oro S, Bodemer C.

Ann Dermatol Venereol. 2018 Dec;145(12):795-801. doi: 10.1016/j.annder.2018.09.595. Epub 2018 Nov 9. French. No abstract available.


Idiopathic Stevens-Johnson syndrome and toxic epidermal necrolysis: Prevalence and patients' characteristics.

Chaby G, Ingen-Housz-Oro S, De Prost N, Wolkenstein P, Chosidow O, Fardet L.

J Am Acad Dermatol. 2019 May;80(5):1453-1455. doi: 10.1016/j.jaad.2018.10.058. Epub 2018 Nov 2. No abstract available.


Febrile ulceronecrotic Mucha Habermann disease mimicking aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma: a diagnostic challenge.

Lalevee S, Ortonne N, Hotz C, Schlemmer F, Beldi-Ferchiou A, Delfau-Larue MH, Wolkenstein P, Chosidow O, Ingen-Housz-Oro S.

Eur J Dermatol. 2018 Dec 1;28(6):834-835. doi: 10.1684/ejd.2018.3410. No abstract available.


Large International Validation of ABSIS and PDAI Pemphigus Severity Scores.

Hébert V, Boulard C, Houivet E, Duvert Lehembre S, Borradori L, Della Torre R, Feliciani C, Fania L, Zambruno G, Camaioni DB, Didona B, Marinovic B, Schmidt E, Schumacher N, Hünefeld C, Schanz S, Kern JS, Hofmann S, Bouyeure AC, Picard-Dahan C, Prost-Squarcioni C, Caux F, Alexandre M, Ingen-Housz-Oro S, Bagot M, Tancrede-Bohin E, Bouaziz JD, Franck N, Vabres P, Labeille B, Richard MA, Delaporte E, Dupuy A, D'Incan M, Quereux G, Skowro F, Paul C, Livideanu CB, Beylot-Barry M, Doutre MS, Avenel-Audran M, Bedane C, Bernard P, Machet L, Maillard H, Jullien D, Debarbieux S, Sassolas B, Misery L, Abasq C, Dereure O, Lagoutte P, Ferranti V, Werth VP, Murrell DF, Hertl M, Benichou J, Joly P; French Study Group on Autoimmune Bullous Skin Diseases; Autoimmune Bullous Skin Disease Task Force of the European Academy of Dermatology and Venereology.

J Invest Dermatol. 2019 Jan;139(1):31-37. doi: 10.1016/j.jid.2018.04.042. Epub 2018 Oct 6. Review.


Treatment of mycosis fungoides and Sézary syndrome with romidepsin: a series of 32 cases from the French Study Group for Cutaneous Lymphoma.

Deschamps O, Ram-Wolff C, Beylot-Barry M, Grange F, Skowron F, Dereure O, Boulinguez S, Aubin F, Ingen-Housz-Oro S, Bagot M; French Study Group for Cutaneous Lymphoma.

Br J Dermatol. 2019 Feb;180(2):423-424. doi: 10.1111/bjd.17269. Epub 2018 Nov 22. No abstract available.


Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: Proportion and determinants of underreporting to pharmacovigilance.

Chaby G, Lebrun-Vignes B, Haddad C, Hemery F, Ingen-Housz-Oro S, de Prost N, Wolkenstein P, Chosidow O, Fardet L.

J Allergy Clin Immunol Pract. 2019 Apr;7(4):1344-1346. doi: 10.1016/j.jaip.2018.09.028. Epub 2018 Oct 5. No abstract available.


Post-traumatic stress disorder in Stevens-Johnson syndrome and toxic epidermal necrolysis: prevalence and risk factors. A prospective study of 31 patients.

Hefez L, Zaghbib K, Sbidian E, Valeyrie-Allanore L, Allain M, Duong TA, Colin A, Bellivier F, Romano H, de Prost N, Chazelas K, Chosidow O, Wolkenstein P, Ingen-Housz-Oro S.

Br J Dermatol. 2019 May;180(5):1206-1213. doi: 10.1111/bjd.17267. Epub 2018 Dec 3.


Valaciclovir: a culprit drug for drug reaction with eosinophilia and systemic symptoms not to be neglected. Three cases.

Ingen-Housz-Oro S, Bernier C, Gener G, Fichel F, Barbaud A, Lebrun-Vignes B, Assier H.

Br J Dermatol. 2019 Mar;180(3):666-667. doi: 10.1111/bjd.17207. Epub 2018 Nov 1. No abstract available.


[Autoimmune bullous diseases with gingival expression: A proposed non-iatrogenic gingival biopsy technique].

Dridi SM, Bellakhdar F, Ortonne N, Bayet K, Ingen-Housz-Oro S, Gaultier F.

Ann Dermatol Venereol. 2018 Oct;145(10):572-577. doi: 10.1016/j.annder.2018.06.005. Epub 2018 Aug 22. French.


[FIMARAD: The French rare skin diseases network].

Bodemer C, Taïeb C, Vidaud D, Ingen-Housz-Oro S, Gène R.

Ann Dermatol Venereol. 2018 Aug - Sep;145(8-9):544-547. doi: 10.1016/j.annder.2018.05.008. Epub 2018 Jul 31. French. No abstract available.


Association Between Severe Acute Contact Dermatitis Due to Nigella sativa Oil and Epidermal Apoptosis.

Gaudin O, Toukal F, Hua C, Ortonne N, Assier H, Jannic A, Giménez-Arnau E, Wolkenstein P, Chosidow O, Ingen-Housz-Oro S.

JAMA Dermatol. 2018 Sep 1;154(9):1062-1065. doi: 10.1001/jamadermatol.2018.2120.


A large epidemiological study of erythema multiforme in France, with emphasis on treatment choices.

Kechichian E, Ingen-Housz-Oro S, Sbidian E, Hemery F, Bernier C, Fite C, Delaunay J, Staumont-Sallé D, Toukal F, Dupin N, Abasq C, Samimi M, Picard C, Hebert V, Prost C, Monfort JB, Milpied B, Wolkenstein P, Chosidow O.

Br J Dermatol. 2018 Oct;179(4):1009-1011. doi: 10.1111/bjd.16928. Epub 2018 Aug 16. No abstract available.


Gliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients.

Gaudin O, Seta V, Alexandre M, Bohelay G, Aucouturier F, Mignot-Grootenboer S, Ingen-Housz-Oro S, Bernardeschi C, Schneider P, Mellottee B, Caux F, Prost-Squarcioni C.

Front Immunol. 2018 May 24;9:1030. doi: 10.3389/fimmu.2018.01030. eCollection 2018.


[Pemphigus and herpes: Multicentre survey and literature review].

Merlant M, Seta V, Bernard P, Fourati S, Meritet JF, Wolkenstein P, Dupin N, Joly P, Chosidow O, Ingen-Housz-Oro S.

Ann Dermatol Venereol. 2018 Aug - Sep;145(8-9):477-485. doi: 10.1016/j.annder.2018.03.169. Epub 2018 Jun 14. Review. French.


Polysensitivity in delayed cutaneous adverse drug reactions to macrolides, clindamycin and pristinamycin: clinical history and patch testing.

El Khoury M, Assier H, Gener G, Paul M, Haddad C, Chosidow O, Wolkenstein P, Ingen-Housz-Oro S.

Br J Dermatol. 2018 Oct;179(4):978-979. doi: 10.1111/bjd.16738. Epub 2018 Jul 20. No abstract available.


[Treatment of severe cutaneous adverse drug reactions].

Ingen-Housz-Oro S, Duong TA, de Prost N, Colin A, Fardet L, Lebrun-Vignes B, Barbaud A, Chosidow O, Wolkenstein P; centre de référence des dermatoses bulleuses toxiques et toxidermies graves et le FISARD.

Ann Dermatol Venereol. 2018 Jun - Jul;145(6-7):454-464. doi: 10.1016/j.annder.2018.02.014. Epub 2018 Apr 13. French. No abstract available.


Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins).

Ingen-Housz-Oro S, Duong TA, Bensaid B, Bellon N, de Prost N, Lu D, Lebrun-Vignes B, Gueudry J, Bequignon E, Zaghbib K, Royer G, Colin A, Do-Pham G, Bodemer C, Ortonne N, Barbaud A, Fardet L, Chosidow O, Wolkenstein P; French National Reference Center for Toxic Bullous Dermatoses.

Orphanet J Rare Dis. 2018 Apr 10;13(1):56. doi: 10.1186/s13023-018-0793-7.


Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome due to ethambutol.

Gest N, Ingen-Housz-Oro S, Gener G, Bellanger M, Henn A, Gallien S, Flateau C.

Med Mal Infect. 2018 Jun;48(4):302-305. doi: 10.1016/j.medmal.2018.03.001. Epub 2018 Mar 27. No abstract available.


A Single-Arm Phase II Trial of Lenalidomide in Relapsing or Refractory Primary Cutaneous Large B-Cell Lymphoma, Leg Type.

Beylot-Barry M, Mermin D, Maillard A, Bouabdallah R, Bonnet N, Duval-Modeste AB, Mortier L, Ingen-Housz-Oro S, Ram-Wolff C, Barete S, Dalle S, Maubec E, Quereux G, Templier I, Bagot M, Grange F, Joly P, Vergier B, Vially PJ, Gros A, Pham-Ledard A, Frison E, Merlio JP.

J Invest Dermatol. 2018 Sep;138(9):1982-1989. doi: 10.1016/j.jid.2018.03.1516. Epub 2018 Mar 27.


Clinical and histologic features of Mycoplasma pneumoniae-related erythema multiforme: A single-center series of 33 cases compared with 100 cases induced by other causes.

Amode R, Ingen-Housz-Oro S, Ortonne N, Bounfour T, Pereyre S, Schlemmer F, Bequignon E, Royer G, Wolkenstein P, Chosidow O.

J Am Acad Dermatol. 2018 Jul;79(1):110-117. doi: 10.1016/j.jaad.2018.03.013. Epub 2018 Mar 17.


Epidermal necrolysis and autoimmune diseases: two more observations supporting the concept that 'toxic' epidermal necrolysis can be 'non-toxic'.

Dumas M, Hua C, Hotz C, Velter C, Duong TA, Maraffi T, Ortonne N, Hüe S, Fardet L, de Prost N, Wolkenstein P, Ingen-Housz-Oro S, Chosidow O.

J Eur Acad Dermatol Venereol. 2018 Sep;32(9):e360-e361. doi: 10.1111/jdv.14935. Epub 2018 Mar 30. No abstract available.


Lenalidomide as an Alternative to Thalidomide for Treatment of Recurrent Erythema Multiforme.

Drahy F, Ingen-Housz-Oro S, Grootenboer-Mignot S, Wolkenstein P, Chosidow O.

JAMA Dermatol. 2018 Apr 1;154(4):487-489. doi: 10.1001/jamadermatol.2017.5889. No abstract available.


Cyclosporine for Epidermal Necrolysis: Absence of Beneficial Effect in a Retrospective Cohort of 174 Patients-Exposed/Unexposed and Propensity Score-Matched Analyses.

Poizeau F, Gaudin O, Le Cleach L, Duong TA, Hua C, Hotz C, Ingen-Housz-Oro S, Sbidian E, Zehou O, Colin A, de Prost N, Lebrun-Vignes B, Chosidow O, Wolkenstein P, Fardet L.

J Invest Dermatol. 2018 Jun;138(6):1293-1300. doi: 10.1016/j.jid.2017.12.034. Epub 2018 Jan 31.


T-cell papulosis associated with B-cell malignancy: a distinctive clinicopathologic entity.

Visseaux L, Durlach A, Barete S, Beylot-Barry M, Bonnet N, Chassine A, Franck N, Herve G, Leclec'h C, Machet L, Ingen-Housz-Oro S, Petrella T, Vergier B, Ortonne N, Grange F.

J Eur Acad Dermatol Venereol. 2018 Sep;32(9):1469-1475. doi: 10.1111/jdv.14805. Epub 2018 Feb 12.


Rituximab as Single Long-term Maintenance Therapy in Patients With Difficult-to-Treat Pemphigus.

Sanchez J, Ingen-Housz-Oro S, Chosidow O, Antonicelli F, Bernard P.

JAMA Dermatol. 2018 Mar 1;154(3):363-365. doi: 10.1001/jamadermatol.2017.5176. No abstract available.


Stevens-Johnson Syndrome During Pregnancy: Case Report of a Newborn Treated With the Culprit Drug.

Velter C, Hotz C, Ingen-Housz-Oro S, Wolkenstein P, Fardet L.

JAMA Dermatol. 2018 Feb 1;154(2):224-225. doi: 10.1001/jamadermatol.2017.4607. No abstract available.


A polymorphous bullous dermatosis.

Drahy F, Hotz C, Ortonne N, Ghoufi L, Grootenboer-Mignot S, Massard C, Perrin MP, Chosidow O, Ingen-Housz-Oro S.

Lancet Oncol. 2017 Dec;18(12):e776. doi: 10.1016/S1470-2045(17)30461-8. No abstract available.


Supplemental Content

Loading ...
Support Center